 Catherine Flaitz
Concepts (766)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dental Caries | 54 | 2017 | 162 | 4.100 |
Why?
| | Mouth Diseases | 19 | 2018 | 40 | 2.700 |
Why?
| | Mouth Neoplasms | 21 | 2012 | 70 | 2.210 |
Why?
| | Cariostatic Agents | 22 | 2014 | 27 | 1.980 |
Why?
| | Diagnosis, Differential | 53 | 2014 | 1331 | 1.840 |
Why?
| | Fluorides | 22 | 2014 | 43 | 1.770 |
Why?
| | Gingival Diseases | 11 | 2012 | 18 | 1.750 |
Why?
| | Dental Enamel | 30 | 2007 | 65 | 1.600 |
Why?
| | Tongue Neoplasms | 5 | 2013 | 20 | 1.390 |
Why?
| | Mouth Mucosa | 20 | 2014 | 79 | 1.370 |
Why?
| | Mandibular Neoplasms | 13 | 2003 | 22 | 1.130 |
Why?
| | Precancerous Conditions | 5 | 2013 | 155 | 1.000 |
Why?
| | AIDS-Related Opportunistic Infections | 15 | 2005 | 115 | 1.000 |
Why?
| | Tooth Remineralization | 8 | 2007 | 12 | 0.940 |
Why?
| | Dental Restoration, Permanent | 10 | 2003 | 40 | 0.940 |
Why?
| | Tooth, Deciduous | 11 | 2006 | 15 | 0.930 |
Why?
| | Ethics, Dental | 3 | 2013 | 3 | 0.910 |
Why?
| | Mandibular Diseases | 6 | 2007 | 9 | 0.880 |
Why?
| | Carcinoma, Squamous Cell | 8 | 2013 | 577 | 0.850 |
Why?
| | Lichen Planus, Oral | 3 | 2013 | 5 | 0.840 |
Why?
| | HIV Infections | 30 | 2013 | 2453 | 0.760 |
Why?
| | Molar | 18 | 2014 | 42 | 0.750 |
Why?
| | Lip Diseases | 5 | 2013 | 6 | 0.750 |
Why?
| | Gingival Neoplasms | 5 | 2001 | 10 | 0.720 |
Why?
| | Pit and Fissure Sealants | 9 | 2007 | 19 | 0.710 |
Why?
| | Humans | 216 | 2018 | 114045 | 0.710 |
Why?
| | Gingiva | 4 | 2012 | 22 | 0.680 |
Why?
| | Odontogenic Tumors | 6 | 2001 | 9 | 0.610 |
Why?
| | Glossitis | 3 | 2003 | 3 | 0.580 |
Why?
| | Burns, Chemical | 2 | 2012 | 25 | 0.570 |
Why?
| | Fluorides, Topical | 9 | 2004 | 13 | 0.560 |
Why?
| | Sarcoma, Kaposi | 8 | 2002 | 68 | 0.540 |
Why?
| | Drugs, Chinese Herbal | 1 | 2016 | 13 | 0.520 |
Why?
| | Tongue | 7 | 2004 | 66 | 0.500 |
Why?
| | Saliva | 8 | 2003 | 188 | 0.500 |
Why?
| | Male | 87 | 2017 | 55396 | 0.500 |
Why?
| | Laser Therapy | 12 | 2006 | 99 | 0.500 |
Why?
| | Child | 54 | 2018 | 18401 | 0.470 |
Why?
| | Maxillary Diseases | 4 | 2012 | 7 | 0.470 |
Why?
| | Radiography | 19 | 2007 | 803 | 0.470 |
Why?
| | Condylomata Acuminata | 2 | 2013 | 6 | 0.460 |
Why?
| | Acidulated Phosphate Fluoride | 12 | 2007 | 12 | 0.460 |
Why?
| | Resin Cements | 7 | 2010 | 24 | 0.460 |
Why?
| | Dental Sac | 1 | 2014 | 1 | 0.460 |
Why?
| | Gingival Hypertrophy | 1 | 2014 | 1 | 0.460 |
Why?
| | Dental Bonding | 6 | 2010 | 30 | 0.460 |
Why?
| | Herpesvirus 4, Human | 9 | 2007 | 124 | 0.450 |
Why?
| | Candidiasis, Oral | 12 | 2007 | 16 | 0.440 |
Why?
| | Root Caries | 9 | 2014 | 10 | 0.440 |
Why?
| | Dental Plaque | 6 | 2004 | 15 | 0.440 |
Why?
| | Granular Cell Tumor | 2 | 2003 | 7 | 0.420 |
Why?
| | Carcinoma, Mucoepidermoid | 4 | 2000 | 15 | 0.410 |
Why?
| | Salivary Gland Neoplasms | 4 | 2000 | 31 | 0.400 |
Why?
| | Odontogenic Cysts | 1 | 2012 | 1 | 0.400 |
Why?
| | Purpura | 1 | 2012 | 13 | 0.390 |
Why?
| | Dentifrices | 3 | 2014 | 4 | 0.390 |
Why?
| | Leukoplakia, Hairy | 8 | 2004 | 8 | 0.390 |
Why?
| | Ethics, Professional | 1 | 2011 | 14 | 0.380 |
Why?
| | Jaw Diseases | 2 | 2005 | 3 | 0.380 |
Why?
| | Analysis of Variance | 22 | 2007 | 1218 | 0.380 |
Why?
| | Gingivitis | 2 | 2010 | 12 | 0.380 |
Why?
| | Composite Resins | 7 | 2010 | 103 | 0.370 |
Why?
| | Tooth Diseases | 2 | 2001 | 13 | 0.370 |
Why?
| | Gingival Hyperplasia | 1 | 2010 | 3 | 0.370 |
Why?
| | Child, Preschool | 30 | 2017 | 9114 | 0.370 |
Why?
| | Oral Ulcer | 7 | 2003 | 9 | 0.360 |
Why?
| | Cheek | 2 | 2000 | 16 | 0.350 |
Why?
| | Gingivitis, Necrotizing Ulcerative | 5 | 2003 | 5 | 0.350 |
Why?
| | Female | 71 | 2017 | 59324 | 0.350 |
Why?
| | Sodium Fluoride | 8 | 2013 | 15 | 0.350 |
Why?
| | HIV Seropositivity | 4 | 2007 | 109 | 0.350 |
Why?
| | Lithiasis | 1 | 2009 | 3 | 0.340 |
Why?
| | Fibroma, Ossifying | 3 | 2001 | 3 | 0.340 |
Why?
| | Tooth Eruption | 5 | 2014 | 8 | 0.340 |
Why?
| | Pharyngeal Diseases | 1 | 2009 | 12 | 0.340 |
Why?
| | Schools, Dental | 2 | 2011 | 15 | 0.340 |
Why?
| | Palatine Tonsil | 1 | 2009 | 32 | 0.340 |
Why?
| | Microscopy, Polarization | 15 | 2013 | 30 | 0.330 |
Why?
| | Teaching | 1 | 2011 | 209 | 0.330 |
Why?
| | Adult | 52 | 2013 | 30375 | 0.320 |
Why?
| | Academic Medical Centers | 2 | 2011 | 405 | 0.320 |
Why?
| | Middle Aged | 41 | 2013 | 26605 | 0.320 |
Why?
| | Cysts | 3 | 2002 | 92 | 0.320 |
Why?
| | Glossitis, Benign Migratory | 3 | 2010 | 5 | 0.310 |
Why?
| | Anesthesia, Dental | 5 | 2014 | 18 | 0.310 |
Why?
| | Immunocompromised Host | 6 | 2013 | 192 | 0.300 |
Why?
| | Alveolar Bone Loss | 2 | 2007 | 8 | 0.300 |
Why?
| | Stomatitis, Herpetic | 4 | 2001 | 5 | 0.300 |
Why?
| | Acyclovir | 6 | 2004 | 100 | 0.300 |
Why?
| | Salivary Gland Calculi | 2 | 2000 | 3 | 0.290 |
Why?
| | Dental Materials | 3 | 2003 | 52 | 0.290 |
Why?
| | Dental Care for Chronically Ill | 5 | 2006 | 11 | 0.290 |
Why?
| | Papillomavirus Infections | 3 | 2013 | 261 | 0.290 |
Why?
| | Tooth Demineralization | 8 | 2013 | 10 | 0.290 |
Why?
| | Learning | 1 | 2011 | 346 | 0.290 |
Why?
| | Acquired Immunodeficiency Syndrome | 4 | 2001 | 212 | 0.290 |
Why?
| | Incisor | 4 | 2002 | 16 | 0.280 |
Why?
| | Denture, Complete, Lower | 1 | 2007 | 1 | 0.280 |
Why?
| | Dental Implantation, Endosseous | 1 | 2007 | 3 | 0.280 |
Why?
| | Dental Prosthesis, Implant-Supported | 1 | 2007 | 4 | 0.280 |
Why?
| | Maxillary Neoplasms | 4 | 1995 | 7 | 0.280 |
Why?
| | Dental Implants | 1 | 2007 | 9 | 0.270 |
Why?
| | Gingival Overgrowth | 3 | 2003 | 5 | 0.270 |
Why?
| | Head and Neck Neoplasms | 3 | 2002 | 427 | 0.270 |
Why?
| | Valine | 5 | 2004 | 72 | 0.270 |
Why?
| | Tooth, Unerupted | 2 | 2002 | 2 | 0.270 |
Why?
| | Texas | 8 | 2017 | 188 | 0.260 |
Why?
| | Tooth, Impacted | 3 | 2003 | 8 | 0.260 |
Why?
| | Epstein-Barr Virus Infections | 5 | 2007 | 72 | 0.260 |
Why?
| | Dental Enamel Solubility | 5 | 2006 | 5 | 0.260 |
Why?
| | Epithelium | 8 | 2012 | 295 | 0.260 |
Why?
| | Maxilla | 7 | 2002 | 29 | 0.260 |
Why?
| | Sarcoidosis | 1 | 2007 | 133 | 0.250 |
Why?
| | Mouth Floor | 3 | 2000 | 6 | 0.250 |
Why?
| | Molluscum Contagiosum | 2 | 2002 | 2 | 0.250 |
Why?
| | Lasers | 6 | 2004 | 121 | 0.250 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2005 | 5 | 0.250 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2005 | 34 | 0.240 |
Why?
| | Dental Research | 1 | 2005 | 8 | 0.240 |
Why?
| | Odontoma | 2 | 2003 | 4 | 0.240 |
Why?
| | Cytodiagnosis | 4 | 2012 | 29 | 0.240 |
Why?
| | Cuspid | 2 | 2002 | 10 | 0.240 |
Why?
| | Acid Etching, Dental | 6 | 2001 | 14 | 0.240 |
Why?
| | Dentist-Patient Relations | 3 | 2013 | 5 | 0.240 |
Why?
| | Microscopy, Electron, Scanning | 15 | 2003 | 192 | 0.240 |
Why?
| | Tooth Root | 9 | 2013 | 13 | 0.240 |
Why?
| | Lymphocele | 1 | 2004 | 2 | 0.230 |
Why?
| | Compomers | 2 | 2003 | 2 | 0.230 |
Why?
| | Tongue Diseases | 1 | 2004 | 7 | 0.230 |
Why?
| | Prognosis | 12 | 2002 | 3315 | 0.230 |
Why?
| | Calcium | 5 | 2007 | 1089 | 0.230 |
Why?
| | Biopsy | 7 | 2012 | 1024 | 0.230 |
Why?
| | Calcium Phosphates | 2 | 2004 | 24 | 0.230 |
Why?
| | Warts | 2 | 2001 | 4 | 0.230 |
Why?
| | Glass Ionomer Cements | 5 | 2003 | 9 | 0.220 |
Why?
| | Root Resorption | 3 | 2006 | 4 | 0.220 |
Why?
| | Adolescent | 30 | 2014 | 17800 | 0.220 |
Why?
| | Lymphoma, AIDS-Related | 2 | 2002 | 14 | 0.220 |
Why?
| | Dentists | 2 | 2001 | 18 | 0.220 |
Why?
| | Granuloma, Giant Cell | 2 | 2000 | 4 | 0.220 |
Why?
| | Erythema | 2 | 2001 | 25 | 0.220 |
Why?
| | Bites, Human | 2 | 2014 | 3 | 0.210 |
Why?
| | Dental Amalgam | 1 | 2002 | 2 | 0.210 |
Why?
| | Cytomegalovirus Infections | 2 | 1996 | 180 | 0.210 |
Why?
| | Universities | 1 | 2005 | 338 | 0.200 |
Why?
| | Dental Caries Susceptibility | 10 | 2006 | 12 | 0.200 |
Why?
| | Cyclosporine | 1 | 2003 | 161 | 0.200 |
Why?
| | Parotitis | 2 | 2003 | 6 | 0.200 |
Why?
| | Crowns | 1 | 2002 | 3 | 0.200 |
Why?
| | Personal Autonomy | 2 | 2013 | 39 | 0.200 |
Why?
| | Cheilitis | 2 | 2003 | 3 | 0.190 |
Why?
| | Toothpastes | 2 | 2000 | 4 | 0.190 |
Why?
| | Sialadenitis | 1 | 2001 | 1 | 0.190 |
Why?
| | Sublingual Gland | 1 | 2001 | 1 | 0.190 |
Why?
| | Salivary Glands, Minor | 2 | 2000 | 8 | 0.190 |
Why?
| | Diazepam | 3 | 1986 | 26 | 0.190 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 641 | 0.190 |
Why?
| | Rhabdomyosarcoma | 1 | 2002 | 56 | 0.190 |
Why?
| | Blister | 1 | 2001 | 43 | 0.190 |
Why?
| | Evidence-Based Dentistry | 2 | 2012 | 6 | 0.190 |
Why?
| | Pediatric Dentistry | 3 | 2001 | 8 | 0.190 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2013 | 256 | 0.190 |
Why?
| | Fibroma | 1 | 2001 | 21 | 0.190 |
Why?
| | Durapatite | 2 | 2004 | 35 | 0.180 |
Why?
| | Burkitt Lymphoma | 1 | 2001 | 52 | 0.180 |
Why?
| | Hair Dyes | 1 | 2000 | 2 | 0.180 |
Why?
| | Lip | 2 | 2000 | 20 | 0.180 |
Why?
| | Candida | 4 | 2006 | 32 | 0.180 |
Why?
| | Disease Progression | 5 | 2013 | 2371 | 0.180 |
Why?
| | Sjogren's Syndrome | 1 | 2001 | 41 | 0.180 |
Why?
| | Malpractice | 1 | 2001 | 37 | 0.180 |
Why?
| | Dental Care for Children | 2 | 1999 | 11 | 0.180 |
Why?
| | Neoplasms, Second Primary | 1 | 2002 | 92 | 0.180 |
Why?
| | Palate, Hard | 1 | 2000 | 4 | 0.180 |
Why?
| | Palatal Neoplasms | 1 | 2000 | 4 | 0.180 |
Why?
| | Neuroma | 1 | 2000 | 11 | 0.180 |
Why?
| | Saliva, Artificial | 7 | 2014 | 10 | 0.180 |
Why?
| | Biomarkers, Tumor | 4 | 2004 | 1032 | 0.170 |
Why?
| | Argon | 15 | 2004 | 20 | 0.170 |
Why?
| | Focal Epithelial Hyperplasia | 1 | 2000 | 1 | 0.170 |
Why?
| | Lymphangioma | 1 | 2000 | 7 | 0.170 |
Why?
| | Virus Replication | 6 | 2007 | 395 | 0.170 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2000 | 34 | 0.170 |
Why?
| | Lipoma | 1 | 2000 | 14 | 0.170 |
Why?
| | Hyperplasia | 4 | 2003 | 163 | 0.170 |
Why?
| | Calcinosis | 1 | 2002 | 239 | 0.170 |
Why?
| | Child Behavior | 3 | 2014 | 220 | 0.170 |
Why?
| | Herpesvirus 8, Human | 2 | 1997 | 61 | 0.170 |
Why?
| | Mineral Waters | 2 | 1989 | 2 | 0.170 |
Why?
| | Mandible | 5 | 2007 | 59 | 0.170 |
Why?
| | Self-Injurious Behavior | 1 | 2000 | 114 | 0.160 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2014 | 507 | 0.160 |
Why?
| | Candidiasis | 1 | 1999 | 51 | 0.160 |
Why?
| | Oncogenic Viruses | 1 | 1998 | 3 | 0.160 |
Why?
| | Vinblastine | 3 | 1995 | 63 | 0.160 |
Why?
| | Attitude to Health | 2 | 2013 | 398 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2013 | 1204 | 0.160 |
Why?
| | Light | 5 | 2012 | 336 | 0.150 |
Why?
| | Facial Dermatoses | 3 | 2008 | 14 | 0.150 |
Why?
| | Statistics, Nonparametric | 7 | 2007 | 384 | 0.150 |
Why?
| | Dens in Dente | 2 | 1990 | 2 | 0.150 |
Why?
| | Osteoradionecrosis | 1 | 1998 | 2 | 0.150 |
Why?
| | Nose Diseases | 1 | 1998 | 10 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2011 | 850 | 0.150 |
Why?
| | Pulpotomy | 2 | 1989 | 2 | 0.150 |
Why?
| | Palate | 1 | 1998 | 28 | 0.150 |
Why?
| | Myxoma | 1 | 1997 | 11 | 0.150 |
Why?
| | X-Ray Film | 2 | 1987 | 5 | 0.140 |
Why?
| | Cleft Lip | 1 | 2017 | 31 | 0.140 |
Why?
| | Food Hypersensitivity | 1 | 2001 | 251 | 0.140 |
Why?
| | Specimen Handling | 1 | 1998 | 153 | 0.140 |
Why?
| | Periodontal Diseases | 3 | 2007 | 54 | 0.140 |
Why?
| | Cleft Palate | 1 | 2017 | 49 | 0.140 |
Why?
| | Cooperative Behavior | 4 | 2011 | 376 | 0.140 |
Why?
| | Leukoplakia, Oral | 2 | 2011 | 6 | 0.140 |
Why?
| | Melanoma | 2 | 2000 | 620 | 0.140 |
Why?
| | Taste Buds | 1 | 1999 | 208 | 0.140 |
Why?
| | Xylitol | 2 | 2014 | 3 | 0.140 |
Why?
| | Tooth Bleaching | 1 | 1996 | 3 | 0.130 |
Why?
| | Chronic Disease | 2 | 2018 | 1577 | 0.130 |
Why?
| | Peroxides | 1 | 1996 | 20 | 0.130 |
Why?
| | Ameloblastoma | 2 | 1993 | 5 | 0.130 |
Why?
| | Acids | 2 | 2012 | 16 | 0.130 |
Why?
| | Urea | 1 | 1996 | 66 | 0.130 |
Why?
| | Ulcer | 1 | 1996 | 28 | 0.130 |
Why?
| | Anesthesia, Rectal | 2 | 1985 | 2 | 0.130 |
Why?
| | Langerhans Cells | 2 | 2007 | 11 | 0.130 |
Why?
| | Sex Factors | 4 | 2016 | 1706 | 0.130 |
Why?
| | HIV Seronegativity | 4 | 2007 | 24 | 0.130 |
Why?
| | Age Factors | 6 | 2016 | 2885 | 0.130 |
Why?
| | Jaw Neoplasms | 1 | 1995 | 2 | 0.130 |
Why?
| | Osteomyelitis | 2 | 2000 | 105 | 0.130 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 1995 | 5 | 0.130 |
Why?
| | Acculturation | 1 | 2016 | 51 | 0.120 |
Why?
| | Risk Factors | 10 | 2018 | 8614 | 0.120 |
Why?
| | Dental Cavity Preparation | 5 | 2003 | 6 | 0.120 |
Why?
| | Recurrence | 5 | 2003 | 925 | 0.120 |
Why?
| | Orthodontic Brackets | 3 | 2010 | 13 | 0.120 |
Why?
| | Phosphates | 4 | 2013 | 155 | 0.120 |
Why?
| | Mass Screening | 2 | 2012 | 979 | 0.120 |
Why?
| | Tooth Eruption, Ectopic | 2 | 2003 | 2 | 0.120 |
Why?
| | Gingival Hemorrhage | 1 | 2014 | 2 | 0.110 |
Why?
| | Epithelial Cells | 4 | 2007 | 946 | 0.110 |
Why?
| | Hernia | 1 | 2014 | 8 | 0.110 |
Why?
| | Surface Properties | 7 | 2003 | 385 | 0.110 |
Why?
| | Apatites | 2 | 2004 | 4 | 0.110 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 3 | 2000 | 51 | 0.110 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2011 | 307 | 0.110 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 1995 | 181 | 0.110 |
Why?
| | Diastema | 1 | 1993 | 3 | 0.110 |
Why?
| | Infant | 10 | 2002 | 7943 | 0.110 |
Why?
| | Conscious Sedation | 1 | 2014 | 78 | 0.110 |
Why?
| | Fat Necrosis | 1 | 1993 | 8 | 0.110 |
Why?
| | Tooth Abnormalities | 2 | 2001 | 12 | 0.110 |
Why?
| | Hypercalcemia | 1 | 1993 | 19 | 0.110 |
Why?
| | Papillomaviridae | 3 | 2000 | 101 | 0.110 |
Why?
| | Chromosome Aberrations | 2 | 2005 | 134 | 0.110 |
Why?
| | Hypnotics and Sedatives | 1 | 2014 | 133 | 0.110 |
Why?
| | Aurothioglucose | 1 | 1993 | 6 | 0.110 |
Why?
| | Lichen Planus | 1 | 1993 | 3 | 0.110 |
Why?
| | Antiviral Agents | 6 | 2004 | 642 | 0.110 |
Why?
| | Curriculum | 2 | 2011 | 813 | 0.100 |
Why?
| | Human papillomavirus 16 | 1 | 2013 | 26 | 0.100 |
Why?
| | Low-Level Light Therapy | 2 | 2004 | 2 | 0.100 |
Why?
| | Wound Healing | 2 | 2005 | 254 | 0.100 |
Why?
| | Acrylic Resins | 3 | 2007 | 38 | 0.100 |
Why?
| | DMF Index | 5 | 2003 | 22 | 0.100 |
Why?
| | Cariogenic Agents | 2 | 2014 | 2 | 0.100 |
Why?
| | Tooth Erosion | 1 | 2012 | 3 | 0.100 |
Why?
| | Candy | 1 | 2012 | 4 | 0.100 |
Why?
| | Adolescent Behavior | 2 | 2002 | 486 | 0.100 |
Why?
| | Dentin | 5 | 2001 | 22 | 0.100 |
Why?
| | Moral Development | 1 | 2011 | 2 | 0.100 |
Why?
| | Schools, Health Occupations | 1 | 2011 | 6 | 0.100 |
Why?
| | Simplexvirus | 3 | 1998 | 80 | 0.100 |
Why?
| | Quality of Life | 2 | 2013 | 2343 | 0.100 |
Why?
| | Dental Hygienists | 1 | 2011 | 11 | 0.090 |
Why?
| | Keratins | 1 | 2012 | 176 | 0.090 |
Why?
| | Administrative Personnel | 1 | 2011 | 29 | 0.090 |
Why?
| | Staff Development | 1 | 2011 | 39 | 0.090 |
Why?
| | Bioethical Issues | 1 | 2011 | 8 | 0.090 |
Why?
| | Organizational Objectives | 1 | 2011 | 66 | 0.090 |
Why?
| | Dental Cavity Lining | 2 | 2002 | 2 | 0.090 |
Why?
| | General Practice, Dental | 3 | 2006 | 5 | 0.090 |
Why?
| | Dental Alloys | 3 | 2002 | 5 | 0.090 |
Why?
| | Truth Disclosure | 1 | 2011 | 39 | 0.090 |
Why?
| | Secondary Prevention | 2 | 2002 | 221 | 0.090 |
Why?
| | Alphapapillomavirus | 1 | 2011 | 36 | 0.090 |
Why?
| | Dentin-Bonding Agents | 3 | 2003 | 15 | 0.090 |
Why?
| | Professional Competence | 1 | 2011 | 81 | 0.090 |
Why?
| | Stomatitis, Aphthous | 2 | 2001 | 10 | 0.090 |
Why?
| | DNA, Viral | 5 | 2004 | 349 | 0.090 |
Why?
| | HIV-1 | 1 | 1996 | 768 | 0.090 |
Why?
| | Problem-Based Learning | 1 | 2011 | 77 | 0.090 |
Why?
| | Medical History Taking | 1 | 1991 | 115 | 0.090 |
Why?
| | Organizational Innovation | 1 | 2011 | 132 | 0.090 |
Why?
| | Aged | 12 | 2012 | 18969 | 0.090 |
Why?
| | Polyvinyls | 2 | 2007 | 17 | 0.090 |
Why?
| | Faculty | 1 | 2011 | 126 | 0.090 |
Why?
| | Orthodontic Appliances | 2 | 2001 | 10 | 0.090 |
Why?
| | Parents | 2 | 2016 | 1181 | 0.090 |
Why?
| | Formocresols | 2 | 1989 | 2 | 0.090 |
Why?
| | Choice Behavior | 1 | 2011 | 150 | 0.080 |
Why?
| | Collagen | 1 | 2012 | 414 | 0.080 |
Why?
| | Gingival Recession | 2 | 2007 | 6 | 0.080 |
Why?
| | Infant, Newborn | 7 | 2002 | 5038 | 0.080 |
Why?
| | Periapical Diseases | 1 | 1989 | 1 | 0.080 |
Why?
| | Pulpectomy | 1 | 1989 | 1 | 0.080 |
Why?
| | Dental Clinics | 2 | 2001 | 4 | 0.080 |
Why?
| | Statistics as Topic | 4 | 2001 | 291 | 0.080 |
Why?
| | Program Development | 1 | 2011 | 339 | 0.080 |
Why?
| | Cell Division | 3 | 2000 | 754 | 0.080 |
Why?
| | Tin Fluorides | 2 | 1988 | 3 | 0.080 |
Why?
| | Water Supply | 1 | 1989 | 67 | 0.080 |
Why?
| | Vaccination | 1 | 1996 | 1202 | 0.080 |
Why?
| | Proliferating Cell Nuclear Antigen | 2 | 2000 | 49 | 0.080 |
Why?
| | Drug Combinations | 2 | 2001 | 286 | 0.070 |
Why?
| | Hamartoma | 1 | 2008 | 20 | 0.070 |
Why?
| | Nevus | 1 | 2008 | 26 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 4 | 2006 | 256 | 0.070 |
Why?
| | Photomicrography | 2 | 2000 | 7 | 0.070 |
Why?
| | Follow-Up Studies | 5 | 2014 | 4392 | 0.070 |
Why?
| | Porosity | 3 | 2003 | 88 | 0.070 |
Why?
| | Xerostomia | 3 | 2000 | 19 | 0.070 |
Why?
| | Radicular Cyst | 2 | 1998 | 2 | 0.070 |
Why?
| | In Vitro Techniques | 5 | 2002 | 1003 | 0.070 |
Why?
| | Prevalence | 6 | 2001 | 2247 | 0.070 |
Why?
| | Prospective Studies | 6 | 2014 | 6195 | 0.070 |
Why?
| | Dental Restoration Failure | 2 | 2006 | 5 | 0.070 |
Why?
| | Viral Matrix Proteins | 3 | 2004 | 24 | 0.070 |
Why?
| | Denture, Overlay | 1 | 2007 | 5 | 0.070 |
Why?
| | Jaw, Edentulous | 1 | 2007 | 6 | 0.070 |
Why?
| | Dermatitis, Allergic Contact | 2 | 2000 | 63 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 1988 | 237 | 0.070 |
Why?
| | Denture Bases | 1 | 2006 | 3 | 0.070 |
Why?
| | Denture, Complete, Upper | 1 | 2006 | 3 | 0.070 |
Why?
| | Chromium Alloys | 1 | 2006 | 5 | 0.070 |
Why?
| | Osseointegration | 1 | 2007 | 37 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 2011 | 666 | 0.070 |
Why?
| | Tooth Mobility | 2 | 2006 | 5 | 0.070 |
Why?
| | Dental Prophylaxis | 2 | 2003 | 6 | 0.070 |
Why?
| | HIV | 3 | 1998 | 208 | 0.070 |
Why?
| | Dental Cements | 2 | 2002 | 20 | 0.070 |
Why?
| | Thermodynamics | 4 | 2001 | 380 | 0.070 |
Why?
| | Practice Patterns, Dentists' | 1 | 2006 | 3 | 0.070 |
Why?
| | Root Canal Therapy | 1 | 2006 | 6 | 0.070 |
Why?
| | Insurance Claim Reporting | 1 | 2006 | 21 | 0.070 |
Why?
| | Root Canal Irrigants | 1 | 1986 | 3 | 0.070 |
Why?
| | Neoplasm Staging | 4 | 2010 | 1162 | 0.060 |
Why?
| | Treatment Outcome | 6 | 2007 | 9049 | 0.060 |
Why?
| | Silicon | 1 | 2005 | 13 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2017 | 3003 | 0.060 |
Why?
| | Education, Dental | 1 | 2006 | 24 | 0.060 |
Why?
| | Implants, Experimental | 1 | 2005 | 18 | 0.060 |
Why?
| | Glass | 1 | 2005 | 42 | 0.060 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2005 | 15 | 0.060 |
Why?
| | Resins, Plant | 2 | 2002 | 3 | 0.060 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2000 | 150 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 945 | 0.060 |
Why?
| | Denture Design | 2 | 2006 | 4 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 56 | 0.060 |
Why?
| | Biomedical and Dental Materials | 1 | 2005 | 1 | 0.060 |
Why?
| | Molar, Third | 1 | 1985 | 6 | 0.060 |
Why?
| | Denture, Complete | 1 | 2005 | 4 | 0.060 |
Why?
| | Cytoplasmic Granules | 1 | 2005 | 81 | 0.060 |
Why?
| | Retrospective Studies | 8 | 2017 | 12521 | 0.060 |
Why?
| | Antifungal Agents | 3 | 2005 | 128 | 0.060 |
Why?
| | Pathology, Oral | 1 | 2005 | 1 | 0.060 |
Why?
| | Ganciclovir | 2 | 1996 | 48 | 0.060 |
Why?
| | Romania | 2 | 2003 | 10 | 0.060 |
Why?
| | Malocclusion | 2 | 2001 | 23 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2004 | 28 | 0.060 |
Why?
| | Dental Cementum | 2 | 1995 | 4 | 0.060 |
Why?
| | Receptors, CCR5 | 1 | 2004 | 54 | 0.060 |
Why?
| | Phosphoric Acids | 4 | 2001 | 16 | 0.060 |
Why?
| | Vocabulary, Controlled | 1 | 2005 | 41 | 0.060 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 8 | 0.060 |
Why?
| | Mental Recall | 1 | 1986 | 171 | 0.060 |
Why?
| | Osteosarcoma | 2 | 1998 | 65 | 0.060 |
Why?
| | Burning Mouth Syndrome | 2 | 1996 | 5 | 0.060 |
Why?
| | Neoplasm Invasiveness | 3 | 2000 | 438 | 0.060 |
Why?
| | Memory | 1 | 1986 | 209 | 0.060 |
Why?
| | Dental Enamel Permeability | 1 | 2004 | 1 | 0.060 |
Why?
| | Halitosis | 1 | 2003 | 1 | 0.060 |
Why?
| | History, 20th Century | 1 | 2005 | 265 | 0.060 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 80 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2004 | 684 | 0.060 |
Why?
| | Keratosis | 1 | 2003 | 13 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2004 | 87 | 0.050 |
Why?
| | Sex Distribution | 2 | 2002 | 336 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2011 | 944 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2002 | 281 | 0.050 |
Why?
| | Connexins | 1 | 2003 | 49 | 0.050 |
Why?
| | Immunohistochemistry | 4 | 2003 | 1624 | 0.050 |
Why?
| | Mentors | 1 | 2005 | 155 | 0.050 |
Why?
| | Lactobacillus | 1 | 2003 | 24 | 0.050 |
Why?
| | Materials Testing | 4 | 2013 | 337 | 0.050 |
Why?
| | Streptococcus mutans | 1 | 2003 | 8 | 0.050 |
Why?
| | Diet, Cariogenic | 1 | 2003 | 1 | 0.050 |
Why?
| | Secretory Rate | 1 | 2003 | 16 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2003 | 54 | 0.050 |
Why?
| | Dental Leakage | 1 | 2002 | 3 | 0.050 |
Why?
| | Methacrylates | 2 | 2000 | 106 | 0.050 |
Why?
| | Drug Resistance, Viral | 1 | 2003 | 99 | 0.050 |
Why?
| | Polymerase Chain Reaction | 4 | 2003 | 990 | 0.050 |
Why?
| | Stem Cells | 1 | 2007 | 541 | 0.050 |
Why?
| | Tooth Injuries | 2 | 2018 | 4 | 0.050 |
Why?
| | Mouthwashes | 3 | 2010 | 12 | 0.050 |
Why?
| | Remission Induction | 1 | 2003 | 233 | 0.050 |
Why?
| | Combined Modality Therapy | 4 | 2004 | 1117 | 0.050 |
Why?
| | Decision Trees | 1 | 2002 | 82 | 0.050 |
Why?
| | Gold Alloys | 1 | 2002 | 1 | 0.050 |
Why?
| | Skin Diseases | 1 | 2003 | 121 | 0.050 |
Why?
| | Cleidocranial Dysplasia | 1 | 2001 | 1 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 269 | 0.050 |
Why?
| | Cosmetic Techniques | 1 | 2002 | 11 | 0.050 |
Why?
| | Sclerosis | 1 | 2001 | 11 | 0.050 |
Why?
| | Diet | 1 | 1989 | 1080 | 0.050 |
Why?
| | Biocompatible Materials | 1 | 2005 | 372 | 0.050 |
Why?
| | Dental Service, Hospital | 1 | 2001 | 1 | 0.050 |
Why?
| | Heart | 1 | 1985 | 613 | 0.050 |
Why?
| | Respiratory System Abnormalities | 1 | 2001 | 12 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2003 | 294 | 0.050 |
Why?
| | Alcohol Drinking | 4 | 2012 | 650 | 0.050 |
Why?
| | Lactic Acid | 2 | 2014 | 272 | 0.050 |
Why?
| | Dental Pulp Necrosis | 1 | 2001 | 1 | 0.050 |
Why?
| | Pericoronitis | 1 | 2001 | 1 | 0.050 |
Why?
| | Caustics | 1 | 2001 | 6 | 0.050 |
Why?
| | Time Factors | 8 | 2014 | 6077 | 0.050 |
Why?
| | 2-Propanol | 1 | 2001 | 19 | 0.050 |
Why?
| | Hypoparathyroidism | 1 | 1981 | 4 | 0.050 |
Why?
| | Dental Enamel Hypoplasia | 1 | 1981 | 6 | 0.050 |
Why?
| | Fishes | 1 | 2001 | 80 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1989 | 1168 | 0.050 |
Why?
| | Zirconium | 1 | 2001 | 4 | 0.050 |
Why?
| | Anti-Infective Agents, Local | 1 | 2001 | 39 | 0.050 |
Why?
| | Salivary Gland Diseases | 1 | 2001 | 2 | 0.050 |
Why?
| | Bicuspid | 3 | 2000 | 13 | 0.050 |
Why?
| | AIDS Serodiagnosis | 1 | 2001 | 28 | 0.050 |
Why?
| | Mandibular Nerve | 1 | 2000 | 4 | 0.050 |
Why?
| | Plasminogen | 1 | 2001 | 29 | 0.050 |
Why?
| | Folliculitis | 1 | 2000 | 1 | 0.050 |
Why?
| | Tooth Crown | 1 | 2000 | 2 | 0.050 |
Why?
| | Liability, Legal | 1 | 2001 | 38 | 0.050 |
Why?
| | Silicates | 1 | 2000 | 11 | 0.050 |
Why?
| | Phenols | 1 | 2001 | 82 | 0.050 |
Why?
| | Arthritis, Juvenile | 1 | 2001 | 42 | 0.040 |
Why?
| | Denture, Partial, Removable | 1 | 2000 | 3 | 0.040 |
Why?
| | Habits | 1 | 2000 | 36 | 0.040 |
Why?
| | Nickel | 2 | 2006 | 50 | 0.040 |
Why?
| | Periodontitis | 1 | 2001 | 41 | 0.040 |
Why?
| | Emergencies | 1 | 2001 | 143 | 0.040 |
Why?
| | Smoking | 4 | 2012 | 1382 | 0.040 |
Why?
| | Granuloma, Pyogenic | 1 | 2000 | 6 | 0.040 |
Why?
| | Polymethacrylic Acids | 1 | 2000 | 61 | 0.040 |
Why?
| | Hyperpigmentation | 1 | 2000 | 11 | 0.040 |
Why?
| | Hair | 1 | 2000 | 65 | 0.040 |
Why?
| | Diffusion | 1 | 2000 | 119 | 0.040 |
Why?
| | Survival Rate | 2 | 2002 | 1638 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2000 | 102 | 0.040 |
Why?
| | Silicic Acid | 1 | 2000 | 2 | 0.040 |
Why?
| | Silicon Dioxide | 1 | 2001 | 88 | 0.040 |
Why?
| | Coloring Agents | 3 | 2012 | 72 | 0.040 |
Why?
| | Complex Mixtures | 1 | 2000 | 11 | 0.040 |
Why?
| | Triclosan | 1 | 2000 | 9 | 0.040 |
Why?
| | Cytomegalovirus | 2 | 1998 | 143 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1611 | 0.040 |
Why?
| | Age Distribution | 3 | 2001 | 341 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 155 | 0.040 |
Why?
| | Nerve Block | 1 | 2000 | 60 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2001 | 288 | 0.040 |
Why?
| | Mucocele | 1 | 1999 | 11 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 511 | 0.040 |
Why?
| | American Dental Association | 2 | 2012 | 7 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2000 | 93 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2007 | 1696 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2003 | 375 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2002 | 385 | 0.040 |
Why?
| | Flavonoids | 1 | 1999 | 66 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2004 | 722 | 0.040 |
Why?
| | Plasminogen Activators | 1 | 1998 | 7 | 0.040 |
Why?
| | Collagenases | 1 | 1998 | 21 | 0.040 |
Why?
| | Herpesviridae | 1 | 1998 | 21 | 0.040 |
Why?
| | Vacuum | 1 | 1998 | 14 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 170 | 0.040 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1998 | 28 | 0.040 |
Why?
| | Injections, Intralesional | 2 | 1995 | 32 | 0.040 |
Why?
| | Gram-Negative Anaerobic Cocci | 1 | 1998 | 1 | 0.040 |
Why?
| | Virus Shedding | 1 | 1998 | 39 | 0.040 |
Why?
| | Evaluation Studies as Topic | 2 | 1989 | 167 | 0.040 |
Why?
| | Suction | 1 | 1998 | 31 | 0.040 |
Why?
| | Equipment Design | 1 | 2000 | 503 | 0.040 |
Why?
| | Arteries | 1 | 2000 | 246 | 0.040 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 1998 | 36 | 0.040 |
Why?
| | Incidence | 2 | 2012 | 2314 | 0.040 |
Why?
| | Recombination, Genetic | 1 | 1999 | 176 | 0.040 |
Why?
| | Bone Cysts | 1 | 1998 | 11 | 0.040 |
Why?
| | Fibrosarcoma | 1 | 1998 | 20 | 0.040 |
Why?
| | Periodontal Cyst | 1 | 1997 | 1 | 0.040 |
Why?
| | Eosinophilic Granuloma | 1 | 1997 | 3 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 269 | 0.040 |
Why?
| | Temperature | 1 | 2000 | 564 | 0.040 |
Why?
| | Cytokines | 1 | 2005 | 1824 | 0.040 |
Why?
| | Early Detection of Cancer | 2 | 2012 | 305 | 0.040 |
Why?
| | Motor Skills | 1 | 1998 | 82 | 0.040 |
Why?
| | United States | 5 | 2012 | 12137 | 0.040 |
Why?
| | Nose | 1 | 1998 | 55 | 0.040 |
Why?
| | Oropharyngeal Neoplasms | 1 | 1998 | 39 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2001 | 493 | 0.040 |
Why?
| | Hemangioma | 1 | 1997 | 38 | 0.040 |
Why?
| | Survival Analysis | 1 | 2000 | 1206 | 0.040 |
Why?
| | Colony Count, Microbial | 3 | 2006 | 111 | 0.040 |
Why?
| | Anti-HIV Agents | 2 | 2000 | 663 | 0.040 |
Why?
| | Gels | 2 | 2014 | 72 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 538 | 0.030 |
Why?
| | Viral Proteins | 3 | 2004 | 281 | 0.030 |
Why?
| | Radiotherapy | 1 | 1998 | 175 | 0.030 |
Why?
| | Periapical Granuloma | 1 | 1996 | 1 | 0.030 |
Why?
| | Cryptococcosis | 1 | 1997 | 23 | 0.030 |
Why?
| | Herpes Zoster | 1 | 2001 | 330 | 0.030 |
Why?
| | Molecular Sequence Data | 4 | 2004 | 2783 | 0.030 |
Why?
| | Dental Enamel Proteins | 1 | 1996 | 2 | 0.030 |
Why?
| | Role | 1 | 1996 | 32 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1468 | 0.030 |
Why?
| | Digestive System | 1 | 1996 | 27 | 0.030 |
Why?
| | Growth Substances | 1 | 1996 | 138 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1996 | 15 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2001 | 632 | 0.030 |
Why?
| | Choristoma | 1 | 1996 | 21 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 743 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2000 | 6306 | 0.030 |
Why?
| | Pilot Projects | 3 | 2006 | 1360 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1997 | 95 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 517 | 0.030 |
Why?
| | Sarcoma, Small Cell | 1 | 1995 | 1 | 0.030 |
Why?
| | Carcinoma, Basosquamous | 1 | 1995 | 2 | 0.030 |
Why?
| | Placebos | 2 | 1986 | 197 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 1995 | 44 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1996 | 162 | 0.030 |
Why?
| | Virus Activation | 2 | 2007 | 78 | 0.030 |
Why?
| | Cocarcinogenesis | 1 | 1995 | 14 | 0.030 |
Why?
| | Immunization Schedule | 1 | 1996 | 183 | 0.030 |
Why?
| | Virus Latency | 2 | 2007 | 80 | 0.030 |
Why?
| | Hydroxyzine | 1 | 2014 | 3 | 0.030 |
Why?
| | Meperidine | 1 | 2014 | 4 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 2014 | 9 | 0.030 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2014 | 11 | 0.030 |
Why?
| | Akathisia, Drug-Induced | 1 | 2014 | 6 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 1981 | 0.030 |
Why?
| | Clobetasol | 1 | 1994 | 4 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 31 | 0.030 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 1994 | 6 | 0.030 |
Why?
| | Midazolam | 1 | 2014 | 43 | 0.030 |
Why?
| | Genes, Viral | 2 | 2004 | 89 | 0.030 |
Why?
| | Sleep Stages | 1 | 2014 | 61 | 0.030 |
Why?
| | Neoplasms, Multiple Primary | 1 | 1995 | 52 | 0.030 |
Why?
| | Emergency Medical Services | 1 | 2001 | 581 | 0.030 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2014 | 20 | 0.030 |
Why?
| | Adhesiveness | 1 | 1994 | 19 | 0.030 |
Why?
| | Psychomotor Agitation | 1 | 2014 | 65 | 0.030 |
Why?
| | Ketoconazole | 1 | 1993 | 3 | 0.030 |
Why?
| | Vomiting | 1 | 2014 | 122 | 0.030 |
Why?
| | Salivary Proteins and Peptides | 1 | 1993 | 10 | 0.030 |
Why?
| | Awareness | 1 | 2014 | 93 | 0.030 |
Why?
| | Papillon-Lefevre Disease | 1 | 1993 | 1 | 0.030 |
Why?
| | Zidovudine | 1 | 1993 | 77 | 0.030 |
Why?
| | Surface-Active Agents | 1 | 2014 | 79 | 0.030 |
Why?
| | Receptor, ErbB-2 | 1 | 1995 | 300 | 0.030 |
Why?
| | Tooth Loss | 1 | 1993 | 29 | 0.030 |
Why?
| | Tolonium Chloride | 1 | 2012 | 3 | 0.030 |
Why?
| | Bacteria | 1 | 1998 | 725 | 0.030 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 97 | 0.020 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 1991 | 5 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1993 | 222 | 0.020 |
Why?
| | Asymptomatic Diseases | 1 | 2012 | 75 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1995 | 445 | 0.020 |
Why?
| | Double-Blind Method | 2 | 1986 | 1656 | 0.020 |
Why?
| | Control Groups | 1 | 2011 | 10 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2011 | 24 | 0.020 |
Why?
| | Dental Marginal Adaptation | 2 | 2003 | 10 | 0.020 |
Why?
| | Triamcinolone Acetonide | 1 | 1991 | 27 | 0.020 |
Why?
| | Antigens, CD | 1 | 1993 | 440 | 0.020 |
Why?
| | Animals | 5 | 2005 | 31565 | 0.020 |
Why?
| | Sarcoma, Ewing | 1 | 1991 | 65 | 0.020 |
Why?
| | Physical Examination | 1 | 2012 | 221 | 0.020 |
Why?
| | RNA, Viral | 2 | 2004 | 565 | 0.020 |
Why?
| | Bias | 1 | 2011 | 178 | 0.020 |
Why?
| | Review Literature as Topic | 1 | 2010 | 61 | 0.020 |
Why?
| | Cell Adhesion | 2 | 2006 | 426 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 635 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1836 | 0.020 |
Why?
| | Zinc Oxide-Eugenol Cement | 1 | 1989 | 2 | 0.020 |
Why?
| | Genotype | 2 | 2004 | 1757 | 0.020 |
Why?
| | Tooth Extraction | 1 | 1989 | 20 | 0.020 |
Why?
| | Sleep | 1 | 2014 | 631 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 1999 | 118 | 0.020 |
Why?
| | Oral Hemorrhage | 2 | 2001 | 3 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 1998 | 408 | 0.020 |
Why?
| | Sweetening Agents | 1 | 1988 | 37 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 1988 | 192 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 4402 | 0.020 |
Why?
| | Mice, Nude | 2 | 1999 | 628 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 1356 | 0.020 |
Why?
| | Cohort Studies | 2 | 2011 | 4883 | 0.020 |
Why?
| | Flow Cytometry | 3 | 1995 | 1075 | 0.020 |
Why?
| | Prosthodontics | 1 | 2006 | 1 | 0.020 |
Why?
| | Periodontics | 1 | 2006 | 3 | 0.020 |
Why?
| | Endodontics | 1 | 2006 | 3 | 0.020 |
Why?
| | Dentistry, Operative | 1 | 2006 | 4 | 0.020 |
Why?
| | Dental Fistula | 1 | 2006 | 1 | 0.020 |
Why?
| | Periapical Periodontitis | 1 | 2006 | 2 | 0.020 |
Why?
| | Fluorescent Dyes | 2 | 1998 | 298 | 0.020 |
Why?
| | Current Procedural Terminology | 1 | 2006 | 11 | 0.020 |
Why?
| | Suppositories | 1 | 1986 | 3 | 0.020 |
Why?
| | Preanesthetic Medication | 1 | 1986 | 3 | 0.020 |
Why?
| | Anesthesia, Local | 1 | 1986 | 14 | 0.020 |
Why?
| | Lung Neoplasms | 2 | 1995 | 2159 | 0.020 |
Why?
| | Amnesia | 1 | 1986 | 42 | 0.020 |
Why?
| | Pharmaceutical Preparations | 1 | 1988 | 164 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 1997 | 1726 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 913 | 0.020 |
Why?
| | Beryllium | 1 | 2006 | 146 | 0.020 |
Why?
| | Drug Carriers | 1 | 2006 | 112 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2005 | 285 | 0.020 |
Why?
| | Diagnosis, Oral | 1 | 2005 | 6 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2004 | 6 | 0.010 |
Why?
| | Lighting | 1 | 2004 | 25 | 0.010 |
Why?
| | Genes, Immunoglobulin | 1 | 2004 | 26 | 0.010 |
Why?
| | Wettability | 1 | 2004 | 13 | 0.010 |
Why?
| | Sequence Analysis | 1 | 2004 | 35 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1381 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2007 | 3861 | 0.010 |
Why?
| | In Situ Hybridization | 2 | 1996 | 292 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2004 | 72 | 0.010 |
Why?
| | Rabbits | 1 | 2005 | 733 | 0.010 |
Why?
| | Molecular Epidemiology | 1 | 2004 | 62 | 0.010 |
Why?
| | Asthma | 1 | 1997 | 2021 | 0.010 |
Why?
| | Clone Cells | 1 | 2004 | 247 | 0.010 |
Why?
| | Connexin 26 | 1 | 2003 | 8 | 0.010 |
Why?
| | Mouth | 1 | 2004 | 69 | 0.010 |
Why?
| | Sulfur Compounds | 1 | 2003 | 5 | 0.010 |
Why?
| | Dental Plaque Index | 1 | 2003 | 4 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 323 | 0.010 |
Why?
| | Periodontal Index | 1 | 2003 | 11 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 2004 | 135 | 0.010 |
Why?
| | Orthodontic Wires | 1 | 2003 | 5 | 0.010 |
Why?
| | Longitudinal Studies | 2 | 2000 | 2384 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2004 | 2550 | 0.010 |
Why?
| | Tooth Movement Techniques | 1 | 2003 | 11 | 0.010 |
Why?
| | Breath Tests | 1 | 2003 | 82 | 0.010 |
Why?
| | Genetic Markers | 1 | 2004 | 320 | 0.010 |
Why?
| | Cell Count | 1 | 2004 | 303 | 0.010 |
Why?
| | Colorado | 2 | 1990 | 4090 | 0.010 |
Why?
| | Adhesives | 1 | 2003 | 11 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 327 | 0.010 |
Why?
| | Cell Movement | 1 | 2007 | 863 | 0.010 |
Why?
| | Observer Variation | 1 | 2003 | 298 | 0.010 |
Why?
| | Herpes Simplex | 1 | 2003 | 87 | 0.010 |
Why?
| | Stomatitis | 1 | 2002 | 12 | 0.010 |
Why?
| | Pigmentation Disorders | 1 | 2002 | 7 | 0.010 |
Why?
| | Color | 1 | 2002 | 68 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 109 | 0.010 |
Why?
| | Tooth, Supernumerary | 1 | 2001 | 1 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 762 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2001 | 10 | 0.010 |
Why?
| | Pigmentation | 1 | 2002 | 54 | 0.010 |
Why?
| | Toothache | 1 | 2001 | 5 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2004 | 489 | 0.010 |
Why?
| | Anti-Retroviral Agents | 1 | 2003 | 207 | 0.010 |
Why?
| | Blood Protein Disorders | 1 | 2001 | 1 | 0.010 |
Why?
| | Erbium | 1 | 2001 | 5 | 0.010 |
Why?
| | Yttrium | 1 | 2001 | 5 | 0.010 |
Why?
| | Washington | 1 | 2001 | 134 | 0.010 |
Why?
| | Aluminum Silicates | 1 | 2001 | 11 | 0.010 |
Why?
| | Flatfoot | 1 | 2001 | 38 | 0.010 |
Why?
| | Mice | 3 | 2004 | 14843 | 0.010 |
Why?
| | Conjunctivitis | 1 | 2001 | 17 | 0.010 |
Why?
| | Hemodynamics | 1 | 1985 | 1015 | 0.010 |
Why?
| | Dentition, Permanent | 1 | 2000 | 4 | 0.010 |
Why?
| | Odds Ratio | 1 | 2003 | 951 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 460 | 0.010 |
Why?
| | Staining and Labeling | 1 | 2001 | 134 | 0.010 |
Why?
| | Acetates | 1 | 2001 | 94 | 0.010 |
Why?
| | Lymphatic Diseases | 1 | 2000 | 17 | 0.010 |
Why?
| | Cesarean Section | 1 | 2001 | 169 | 0.010 |
Why?
| | Decision Making | 1 | 2006 | 760 | 0.010 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 10 | 0.010 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 1999 | 13 | 0.010 |
Why?
| | Scoliosis | 1 | 2001 | 178 | 0.010 |
Why?
| | Trans-Activators | 1 | 2001 | 366 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2000 | 158 | 0.010 |
Why?
| | Dentin Sensitivity | 1 | 1998 | 2 | 0.010 |
Why?
| | Neck Muscles | 1 | 1998 | 15 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 145 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1999 | 159 | 0.010 |
Why?
| | Logistic Models | 1 | 2003 | 1829 | 0.010 |
Why?
| | Hematoxylin | 1 | 1998 | 3 | 0.010 |
Why?
| | Eosine Yellowish-(YS) | 1 | 1998 | 7 | 0.010 |
Why?
| | Hearing Loss | 1 | 2001 | 183 | 0.010 |
Why?
| | Methenamine | 1 | 1998 | 4 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1310 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1998 | 117 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1998 | 227 | 0.010 |
Why?
| | Point Mutation | 1 | 1999 | 216 | 0.010 |
Why?
| | Paraffin Embedding | 1 | 1998 | 21 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 1998 | 66 | 0.010 |
Why?
| | Mothers | 1 | 2003 | 650 | 0.010 |
Why?
| | Random Allocation | 1 | 1998 | 328 | 0.010 |
Why?
| | Macrophages | 1 | 2004 | 1259 | 0.010 |
Why?
| | Organic Chemicals | 1 | 1998 | 112 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1998 | 270 | 0.010 |
Why?
| | Pneumonia, Pneumocystis | 1 | 1997 | 24 | 0.010 |
Why?
| | Causalgia | 1 | 1996 | 1 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1998 | 845 | 0.010 |
Why?
| | Periodontal Ligament | 1 | 1996 | 2 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1996 | 16 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1996 | 24 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 1998 | 492 | 0.010 |
Why?
| | Substance Abuse, Intravenous | 1 | 1998 | 100 | 0.010 |
Why?
| | Polymers | 1 | 2000 | 448 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1998 | 415 | 0.010 |
Why?
| | Tensile Strength | 1 | 1996 | 88 | 0.010 |
Why?
| | Syndrome | 1 | 1996 | 330 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 2322 | 0.010 |
Why?
| | Phylogeny | 1 | 1999 | 787 | 0.010 |
Why?
| | Digestive System Surgical Procedures | 1 | 1996 | 91 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2004 | 4680 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 508 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 1995 | 3 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1469 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 92 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1311 | 0.010 |
Why?
| | Laryngeal Neoplasms | 1 | 1995 | 27 | 0.010 |
Why?
| | Vincristine | 1 | 1995 | 98 | 0.010 |
Why?
| | Denture, Partial | 1 | 1994 | 2 | 0.010 |
Why?
| | Dental Prosthesis | 1 | 1994 | 2 | 0.010 |
Why?
| | Histological Techniques | 1 | 1994 | 40 | 0.010 |
Why?
| | Inflammation | 1 | 2004 | 2464 | 0.010 |
Why?
| | Patch Tests | 1 | 1994 | 51 | 0.010 |
Why?
| | Aneuploidy | 1 | 1994 | 84 | 0.010 |
Why?
| | HIV Core Protein p24 | 1 | 1993 | 28 | 0.010 |
Why?
| | Homosexuality | 1 | 1993 | 16 | 0.010 |
Why?
| | Ki-1 Antigen | 1 | 1993 | 4 | 0.010 |
Why?
| | Gold | 1 | 1994 | 102 | 0.010 |
Why?
| | Bleomycin | 1 | 1995 | 228 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1998 | 1145 | 0.010 |
Why?
| | Mucins | 1 | 1993 | 61 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1993 | 128 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2114 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 292 | 0.010 |
Why?
| | Cell Cycle | 1 | 1995 | 541 | 0.010 |
Why?
| | Phagocytosis | 1 | 1993 | 349 | 0.010 |
Why?
| | Pregnancy | 1 | 2001 | 5499 | 0.010 |
Why?
| | Cell Survival | 1 | 1993 | 1014 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1998 | 3498 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 4595 | 0.000 |
Why?
| | Neutrophils | 1 | 1993 | 1089 | 0.000 |
Why?
| | Saccharin | 1 | 1988 | 4 | 0.000 |
Why?
| | DNA | 1 | 1994 | 1350 | 0.000 |
Why?
| | Tablets | 1 | 1988 | 36 | 0.000 |
Why?
| | Theophylline | 1 | 1988 | 60 | 0.000 |
Why?
| | Sucrose | 1 | 1988 | 92 | 0.000 |
Why?
| | Solutions | 1 | 1988 | 144 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2272 | 0.000 |
Why?
| | Anticonvulsants | 1 | 1988 | 178 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1988 | 1471 | 0.000 |
Why?
|
|
Flaitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|